Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Rizel, S."'
Autor:
Yerushalmi, R. *, Kramer, M.R., Rizel, S., Sulkes, A., Gelmon, K., Granot, T., Neiman, V., Stemmer, S.M.
Publikováno v:
In Annals of Oncology March 2009 20(3):437-440
Autor:
Hirsh-Yechezkel, G, Chetrit, A, Lubin, F, Friedman, E, Peretz, T, Gershoni, R, Rizel, S, Struewing, J.P, Modan, B
Publikováno v:
In Gynecologic Oncology 2003 89(3):494-498
Autor:
Eitan Friedman, R. Gershoni, J. P. Struewing, Angela Chetrit, Flora Lubin, Rizel S, Baruch Modan, Tamar Peretz, G Hirsh-Yechezkel
Publikováno v:
Gynecologic Oncology. 89:494-498
Objective The objective was to evaluate the prevalence of BRCA1/2 mutations in selected categories of ovarian cancer patients in Israel. Methods Blood samples and specimens of ovarian tumors were obtained in the course of a national case control stud
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Revital Bruchim Bar Sade, Limor Green, Samario Haitchick, Eitan Friedman, Peter J. Oefner, Anna Kruglikova, Efrat Dagan, Robert M.W. Hofstra, Rizel S, Ruth Gershoni Baruch, Inge M. Mulder, Ronit Shiri-Sverdlov, Ziad Abdeen, Boleslaw Goldman, Moshe Z. Papa, Teresa Wagner
Publikováno v:
Human Mutation. 16:491-501
In Ashkenazi (East European) Jews, three predominant mutations in BRCA1 (185delAG and 5382insC) and BRCA2 (6174-delT) account for the majority of germline mutations in high risk breast and/or ovarian cancer families. Among non-Ashkenazi Jews, the 185
Publikováno v:
Gynecologic Oncology. 103:1144-1146
Background. Vulvar cancer rarely sends metastases to distant sites. Case. A 49-year-old female presented with a vulvar mass. The histologic examination revealed an infiltrating lesion with free surgical margins and no evidence of lymph node involveme
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Gynecologic Oncology. 60:393-396
The clinical characteristics and treatment outcome of patients with primary peritoneal serous papillary carcinoma (PPSC) (n = 22) was compared with stage III-IV papillary serous ovarian carcinoma (PSOC) patients (n = 63). There were no statistically
Publikováno v:
International Journal of Gynecologic Cancer. 3:359-362
The site of the first detectable recurrence was recorded in 17 consecutive stage II–IV ovarian carcinoma patients who, after a negative second-look laparotomy, received intraperitoneal chemotherapy with cisplatin and thiosulfate kidney protection.
Publikováno v:
Gynecologic Oncology. 46:222-225
Three courses of intraperitoneal cisplatin chemotherapy with systemic thiosulfate protection were administered to 31 stage II-IV ovarian carcinoma patients who were clinically in complete remission after completion of postoperative cisplatin-based co